- United States
- Latest investment
- Jun 01 2017
- No. of Startups
One Broadway, Cambridge, 02142, USA
- SR One is GlaxoSmithKline's independent corporate healthcare venture capital fund. We invest globally in emerging biotech companies that are focused on drug discovery, development or delivery and have the potential to make products that will have a dramatic benefit to patients.
There is much more to this profile.
Log in or sign up for free to see the whole thing.
Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats